Recent development of micro-nano carriers for oral antineoplastic drug delivery

Chemotherapy is widely recognized as a highly efficacious modality for cancer treatment, involving the administration of chemotherapeutic agents to target and eradicate tumor cells. Currently, oral administration stands as the prevailing and widely utilized method of delivering chemotherapy drugs. H...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongzheng Li, Xiang Chen, Shangrui Rao, Minyu Zhou, Jianhua Lu, Danna Liang, Bingzi Zhu, Letian Meng, Ji Lin, Xiaoya Ding, Qingfei Zhang, Danhong Hu
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Materials Today Bio
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006425000031
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841533267234258944
author Hongzheng Li
Xiang Chen
Shangrui Rao
Minyu Zhou
Jianhua Lu
Danna Liang
Bingzi Zhu
Letian Meng
Ji Lin
Xiaoya Ding
Qingfei Zhang
Danhong Hu
author_facet Hongzheng Li
Xiang Chen
Shangrui Rao
Minyu Zhou
Jianhua Lu
Danna Liang
Bingzi Zhu
Letian Meng
Ji Lin
Xiaoya Ding
Qingfei Zhang
Danhong Hu
author_sort Hongzheng Li
collection DOAJ
description Chemotherapy is widely recognized as a highly efficacious modality for cancer treatment, involving the administration of chemotherapeutic agents to target and eradicate tumor cells. Currently, oral administration stands as the prevailing and widely utilized method of delivering chemotherapy drugs. However, the majority of anti-tumor medications exhibit limited solubility and permeability, and poor stability in harsh gastrointestinal environments, thereby impeding their therapeutic efficacy for chemotherapy. Therefore, more and more micro-nano drug delivery carriers have been developed and used to effectively deliver anti-cancer drugs, which can overcome physiological barriers, facilitate oral administration, and ultimately improve drug efficacy. In this paper, we first discuss the effects of various biological barriers on micro-nano drug carriers and oral administration approach. Then, the development of micro-nano drug carriers based on various biomedical components, such as micelles, dendrimers, hydrogels, liposomes, inorganic nanoparticles, etc. were introduced. Finally, the current dilemma and the potential of oral drug delivery for clinical treatment were discussed. The primary objective of this review is to introduce various oral delivery methods and serve as a point of reference for the advancement of novel oral delivery carriers, with the ultimate goal of informing the development of future clinical applications.
format Article
id doaj-art-d49297d748294178b73cf7062e7fbfb7
institution Kabale University
issn 2590-0064
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Materials Today Bio
spelling doaj-art-d49297d748294178b73cf7062e7fbfb72025-01-17T04:52:15ZengElsevierMaterials Today Bio2590-00642025-02-0130101445Recent development of micro-nano carriers for oral antineoplastic drug deliveryHongzheng Li0Xiang Chen1Shangrui Rao2Minyu Zhou3Jianhua Lu4Danna Liang5Bingzi Zhu6Letian Meng7Ji Lin8Xiaoya Ding9Qingfei Zhang10Danhong Hu11Department of Neurological Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, China; Pharmaceutical Sciences Laboratory, Åbo Akademi University, Turku, 20520, FinlandDepartment of Neurological Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, ChinaDepartment of Neurological Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, China; Pharmaceutical Sciences Laboratory, Åbo Akademi University, Turku, 20520, FinlandDepartment of Neurological Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, ChinaDepartment of Neurological Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, ChinaDepartment of Neurological Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, China; Pharmaceutical Sciences Laboratory, Åbo Akademi University, Turku, 20520, FinlandDepartment of Neurological Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, ChinaDepartment of Neurological Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, ChinaDepartment of Neurological Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, ChinaWenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325000, China; Corresponding author.Department of Neurological Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, China; Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325000, China; Corresponding author. Department of Neurological Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, China.Department of Neurological Rehabilitation, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, China; Corresponding author.Chemotherapy is widely recognized as a highly efficacious modality for cancer treatment, involving the administration of chemotherapeutic agents to target and eradicate tumor cells. Currently, oral administration stands as the prevailing and widely utilized method of delivering chemotherapy drugs. However, the majority of anti-tumor medications exhibit limited solubility and permeability, and poor stability in harsh gastrointestinal environments, thereby impeding their therapeutic efficacy for chemotherapy. Therefore, more and more micro-nano drug delivery carriers have been developed and used to effectively deliver anti-cancer drugs, which can overcome physiological barriers, facilitate oral administration, and ultimately improve drug efficacy. In this paper, we first discuss the effects of various biological barriers on micro-nano drug carriers and oral administration approach. Then, the development of micro-nano drug carriers based on various biomedical components, such as micelles, dendrimers, hydrogels, liposomes, inorganic nanoparticles, etc. were introduced. Finally, the current dilemma and the potential of oral drug delivery for clinical treatment were discussed. The primary objective of this review is to introduce various oral delivery methods and serve as a point of reference for the advancement of novel oral delivery carriers, with the ultimate goal of informing the development of future clinical applications.http://www.sciencedirect.com/science/article/pii/S2590006425000031Micro-nano drug carrierOral administrationAntineoplasticCancer therapy
spellingShingle Hongzheng Li
Xiang Chen
Shangrui Rao
Minyu Zhou
Jianhua Lu
Danna Liang
Bingzi Zhu
Letian Meng
Ji Lin
Xiaoya Ding
Qingfei Zhang
Danhong Hu
Recent development of micro-nano carriers for oral antineoplastic drug delivery
Materials Today Bio
Micro-nano drug carrier
Oral administration
Antineoplastic
Cancer therapy
title Recent development of micro-nano carriers for oral antineoplastic drug delivery
title_full Recent development of micro-nano carriers for oral antineoplastic drug delivery
title_fullStr Recent development of micro-nano carriers for oral antineoplastic drug delivery
title_full_unstemmed Recent development of micro-nano carriers for oral antineoplastic drug delivery
title_short Recent development of micro-nano carriers for oral antineoplastic drug delivery
title_sort recent development of micro nano carriers for oral antineoplastic drug delivery
topic Micro-nano drug carrier
Oral administration
Antineoplastic
Cancer therapy
url http://www.sciencedirect.com/science/article/pii/S2590006425000031
work_keys_str_mv AT hongzhengli recentdevelopmentofmicronanocarriersfororalantineoplasticdrugdelivery
AT xiangchen recentdevelopmentofmicronanocarriersfororalantineoplasticdrugdelivery
AT shangruirao recentdevelopmentofmicronanocarriersfororalantineoplasticdrugdelivery
AT minyuzhou recentdevelopmentofmicronanocarriersfororalantineoplasticdrugdelivery
AT jianhualu recentdevelopmentofmicronanocarriersfororalantineoplasticdrugdelivery
AT dannaliang recentdevelopmentofmicronanocarriersfororalantineoplasticdrugdelivery
AT bingzizhu recentdevelopmentofmicronanocarriersfororalantineoplasticdrugdelivery
AT letianmeng recentdevelopmentofmicronanocarriersfororalantineoplasticdrugdelivery
AT jilin recentdevelopmentofmicronanocarriersfororalantineoplasticdrugdelivery
AT xiaoyading recentdevelopmentofmicronanocarriersfororalantineoplasticdrugdelivery
AT qingfeizhang recentdevelopmentofmicronanocarriersfororalantineoplasticdrugdelivery
AT danhonghu recentdevelopmentofmicronanocarriersfororalantineoplasticdrugdelivery